SS
LMAT icon

Steve Schonfeld’s LeMaitre Vascular LMAT Stock Holding History

Steve Schonfeld’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,960
Closed -$993K – 2409
2025
Q2 		$993K Buy
+11,960
New +$1,000K 0.01% 1312

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steve Schonfeld's LMAT Position: Q3 2025 in Review

Steve Schonfeld sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 11,960 shares — an estimated $993K sold.

Steve Schonfeld first reported a position in LMAT in Q2 2025 and held it in 1 quarter. The position peaked at $993K in Q2 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Steve Schonfeld reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 11,960 LeMaitre Vascular shares in Q3 2025, an estimated $993K.
  • Steve Schonfeld first reported a position in LeMaitre Vascular in Q2 2025 and held it in 1 quarter.
  • Steve Schonfeld's LeMaitre Vascular position peaked at $993K in Q2 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.